Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Abs. Returns |
---|---|---|---|---|
One Week | 2025-05-27 | ₹1,000.00 | ₹993.54 |
-0.65 %
|
Two Week | 2025-05-19 | ₹1,000.00 | ₹984.50 |
-1.55 %
|
1 Month | 2025-05-05 | ₹1,000.00 | ₹993.92 |
-0.61 %
|
Three Months | 2025-03-05 | ₹3,000.00 | ₹3,106.84 |
3.56 %
|
Six Months | 2024-12-05 | ₹6,000.00 | ₹5,983.76 |
-0.27 %
|
One Year | 2024-06-03 | ₹12,000.00 | ₹12,120.92 |
1.01 %
|
Three Year | 2022-06-06 | ₹36,000.00 | ₹50,211.14 |
39.48 %
|
Five Year | 2020-06-04 | ₹60,000.00 | ₹97,127.27 |
61.88 %
|
Since Inception | 2015-12-28 | ₹115,000.00 | ₹272,999.60 |
137.39 %
|
Company Name | Sector | Sector Type | Nav(in %) |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Equity | 13.10 |
Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Equity | 10.06 |
Lupin Ltd. | Pharmaceuticals & Biotechnology | Equity | 9.24 |
Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Equity | 6.88 |
Cipla Ltd. | Pharmaceuticals & Biotechnology | Equity | 6.07 |
Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Equity | 5.57 |
Divi Laboratories Ltd. | Pharmaceuticals & Biotechnology | Equity | 4.89 |
Fortis Healthcare Ltd. | Healthcare Services | Equity | 4.06 |
Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Equity | 3.78 |
Apollo Hospitals Enterprise Ltd. | Healthcare Services | Equity | 3.69 |
Healthcare Global Enterprises Ltd. | Healthcare Services | Equity | 1.89 |
Syngene International Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.82 |
Medi Assist Healthcare Services Ltd. | Insurance | Equity | 2.38 |
Deepak Nitrite Ltd. | Chemicals & Petrochemicals | Equity | 0.52 |
Coromandel International Ltd. | Fertilizers & Agrochemicals | Equity | 0.94 |
Akums Drugs And Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.95 |
Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.76 |
Wockhardt Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.69 |
Sanofi India Ltd. | Pharmaceuticals & Biotechnology | Equity | 1.20 |
Piramal Pharma Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.99 |
Indoco Remedies Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.87 |
Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.80 |
Procter & Gamble Health Ltd. | Consumer Services | Equity | 0.80 |
Sanofi Consumer Healthcare India Ltd. | Consumer Services | Equity | 0.65 |
Glaxosmithkline Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Equity | 0.64 |
Ami Organics Ltd. | Chemicals | Equity | 0.63 |
Medplus Health Services Ltd. | Healthcare Services | Equity | 0.76 |
Cash / Net Current Asset | Unknown | Equity | 2.63 |
India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.
Lock-in times for various investment types
Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.
There are two different types of residual maturity.
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
Axis Innovation Fund - Regular Plan - Growth |
9.98%
|
27.76%
|
14.42%
|
Canara Robeco Consumer Trends Fund - Regular Plan - Growth |
9.95%
|
34.58%
|
16.44%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
BARODA BNP PARIBAS INDIA CONSUMPTION FUND - REGULAR PLAN - GROWTH |
9.90%
|
31.87%
|
18.46%
|
Aditya Birla Sun Life India Reforms Fund - Growth-Regular Plan |
9.88%
|
18.78%
|
8.95%
|
Bajaj Finserv Banking and PSU Fund - Regular Plan - Growth |
9.60%
|
6.82%
|
9.12%
|
LIC MF Banking and PSU Fund - Regular Plan - Growth |
9.52%
|
11.08%
|
7.19%
|
NIPPON INDIA QUANT FUND - INSTITUTIONAL PLAN - GROWTH |
9.51%
|
2.81%
|
3.05%
|
Mirae Asset Banking and PSU Fund - Regular Plan |
9.47%
|
11.15%
|
5.56%
|
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
Tata Corporate Bond Fund - Regular Plan - Growth |
9.80%
|
11.64%
|
6.39%
|
Tata Nifty SDL Plus AAA PSU Bond Dec 2027 60: 40 Index Fund - Regular Plan - Growth |
9.46%
|
12.02%
|
6.95%
|
Tata Floating Rate Fund - Regular Plan - Growth |
9.26%
|
11.44%
|
6.50%
|
Tata Young Citizens Fund - Regular Plan - Growth |
9.24%
|
28.65%
|
4.87%
|
Tata Retirement Savings Fund - Progressive Regular Plan - Growth |
9.20%
|
30.47%
|
14.75%
|
Tata Equity Savings Fund - Regular Plan - Growth |
9.18%
|
16.41%
|
7.51%
|
Tata Multi Asset Opportunities Fund - Regular Plan - Growth |
9.00%
|
24.90%
|
17.36%
|
Tata Short Term Bond Fund - Regular Plan - Growth |
8.80%
|
10.78%
|
7.11%
|
Tata Nifty G-Sec Dec 2026 Index Fund - Regular Plan - Growth |
8.27%
|
8.85%
|
7.53%
|
Tata Nifty Capital Markets Index Fund Regular Plan Growth |
7.99%
|
3.92%
|
18.17%
|
Interested in exploring more about JezzMoney Mutual Fund Distributors Software? Submit the form, and we will respond quickly.